240 related articles for article (PubMed ID: 31941550)
1. Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.
Koromina M; Koutsilieri S; Patrinos GP
Hum Genomics; 2020 Jan; 14(1):4. PubMed ID: 31941550
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
3. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association studies in pharmacogenomics of antidepressants.
Lin E; Lane HY
Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for antidepressant and antipsychotic pharmacogenetics in clinical practice in 2014?
Mulsant BH
Can J Psychiatry; 2014 Feb; 59(2):59-61. PubMed ID: 24881124
[No Abstract] [Full Text] [Related]
6. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
Steimer W
Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
[TBL] [Abstract][Full Text] [Related]
7. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
Fabbri C; Porcelli S; Serretti A
Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of antidepressant drugs.
Horstmann S; Binder EB
Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
[TBL] [Abstract][Full Text] [Related]
9. Progress and prospects in pharmacogenetics of antidepressant drugs.
Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.
Athanasiu L; Smorr LL; Tesli M; Røssberg JI; Sønderby IE; Spigset O; Djurovic S; Andreassen OA
J Psychopharmacol; 2015 Aug; 29(8):884-91. PubMed ID: 25944848
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.
Stevenson JM; Reilly JL; Harris MS; Patel SR; Weiden PJ; Prasad KM; Badner JA; Nimgaonkar VL; Keshavan MS; Sweeney JA; Bishop JR
Transl Psychiatry; 2016 Feb; 6(2):e739. PubMed ID: 26905411
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in Psychiatry.
Corponi F; Fabbri C; Serretti A
Adv Pharmacol; 2018; 83():297-331. PubMed ID: 29801579
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
Narasimhan S; Lohoff FW
Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.
Maust DT; Langa KM; Blow FC; Kales HC
Int J Geriatr Psychiatry; 2017 Feb; 32(2):164-174. PubMed ID: 26889640
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association studies of antidepressant outcome: a brief review.
Laje G; McMahon FJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1553-7. PubMed ID: 21115088
[TBL] [Abstract][Full Text] [Related]
16. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Sang-Hyuk L; Newhouse S; Patel H; Guipponi M; Perroud N; Bondolfi G; O'Donovan M; Lewis G; Biernacka JM; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Uher R; Lewis CM
Pharmacogenomics J; 2018 May; 18(3):413-421. PubMed ID: 29160301
[TBL] [Abstract][Full Text] [Related]
17. Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.
Fabbri C; Minarini A; Niitsu T; Serretti A
Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1093-118. PubMed ID: 24930681
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
20. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.
Yu H; Yan H; Wang L; Li J; Tan L; Deng W; Chen Q; Yang G; Zhang F; Lu T; Yang J; Li K; Lv L; Tan Q; Zhang H; Xiao X; Li M; Ma X; Yang F; Li L; Wang C; Li T; Zhang D; Yue W;
Lancet Psychiatry; 2018 Apr; 5(4):327-338. PubMed ID: 29503163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
